Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PharmaMar reported to National Securities Market Commission that Chugai Pharmaceutical had exercised its right to terminate without cause the License, Development and Commercialization Agreement for Zepsyre in Japan entered on December 22nd, 2016.
read more
Orion Contract Manufacturing has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product, VagiVital.
read more
LabCorp has received approval from the FDA for the UltraQual Multiplex PCR Assay for HCV, HIV-1, HIV-2 and HBV for screening of donated blood plasma.
read more
Under the terms of the agreement Saladax acquired the worldwide exclusive patent rights for diagnostic tests that determine drug levels in patients undergoing treatment with antipsychotic medications.
read more
Syneos Health and Elligo Health Research are entering a strategic collaboration to mobilize a system of accelerated research to reach real-world patients.
read more
Catalent Pharma Solutions announced Graham Brearley, Ph.D., has been appointed as General Manager of the company’s Madison, Wisconsin facility.
read more
TraceLink announced that IBI Lorenzini has selected TraceLink's solutions to ensure compliance with global serialization regulations.
read more
Clinipace expands its leadership team and launches a new brand identity to support its future growth as a midsized CRO.
read more
AbbVie and Calibr announced a collaboration to develop T-cell therapies aimed primarily at cancer, including solid tumors.
read more
LabConnect announces the promotion of three executives to top-level management positions.
read more
The second major release of 2018 offers new reporting capabilities based on standardized performance metrics that are actionable to drive transparency and process improvement.
read more
Advanced Clinical announced continued expansion into the European region at the DIA 2018 Global Annual Meeting.
read more
PCI announced the installation and validation of its latest comprehensive Serialization system, located at its manufacturing Center of Excellence in Tredegar, UK.
read more
Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies to block the CD47 myeloid checkpoint mechanism, today announced the change of the Company’s name to ALX Oncology. The new name and logo will differentiate ALX Oncology ...
read more
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center.
read more